{
    "2021-06-10": [
        [
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)股东和玉高林及高林同创累计减持股份合计206.94万股 减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "高林同创",
                        "减持",
                        "206.94万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：股东和玉高林和高林同创累计减持0.5%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "高林同创",
                        "减持",
                        "0.5%"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因(300676.SZ)股东和玉高林拟减持不超413.91万股 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "拟减持",
                        "413.91万股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：1381.43万股股份将于2月9日上市",
                "features": {
                    "keywords": [
                        "华大基因",
                        "股份上市",
                        "1381.43万股",
                        "2月9日"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：股东和玉高林计划减持不超过1%公司股份 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "拟减持",
                        "1%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：股东和玉高林和高林同创减持约207万股 减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "高林同创",
                        "减持",
                        "207万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：和玉高林拟减持公司不超1%股份 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "拟减持",
                        "1%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：和玉高林拟减持不超1%公司股份 拟减持股份",
                "features": {
                    "keywords": [
                        "华大基因",
                        "和玉高林",
                        "拟减持",
                        "1%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "六年内市场总体规模扩大近五倍 国内独立医学实验室行业发展驶入快车道",
                "features": {
                    "keywords": [
                        "市场总体规模",
                        "扩大五倍",
                        "独立医学实验室",
                        "行业快车道"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}